Literature DB >> 16266833

High-performance liquid chromatographic determination of acetyl-11-keto-alpha-boswellic acid, a novel pentacyclic triterpenoid, in plasma using a fluorinated stationary phase and photodiode array detection: application in pharmacokinetic studies.

Berthold Büchele1, Waltraud Zugmaier, Felicitas Genze, Thomas Simmet.   

Abstract

A rapid, sensitive and selective HPLC separation with photodiode array detection was developed for the analysis of the novel pentacyclic triterpenoid acetyl-11-keto-alpha-boswellic acid. Complete baseline separation of acetyl-11-keto-alpha-boswellic acid from the corresponding isomer acetyl-11-keto-beta-boswellic acid was achieved on a fluorinated stationary phase. The standard curve was linear from 0.98 nmol/l to 196 nmol/l acetyl-11-keto-alpha-boswellic acid. The compound was isolated from chick embryonic plasma using extraction on diatomaceous earth with an overall average extraction yield of 82%. This method was applied in a kinetic study on the chick chorioallantoic membrane model (CAM) and showed unequivocal separation between acetyl-11-keto-alpha-boswellic acid and acetyl-11-keto-beta-boswellic acid unachievable so far.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16266833     DOI: 10.1016/j.jchromb.2005.09.043

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Antagonistic effects of sodium butyrate and N-(4-hydroxyphenyl)-retinamide on prostate cancer.

Authors:  Rainer Kuefer; Felicitas Genze; Waltraud Zugmaier; Richard E Hautmann; Ludwig Rinnab; Juergen E Gschwend; Marina Angelmeier; Aidee Estrada; Berthold Buechele
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

2.  Quantitative Determination of 3-O-Acetyl-11-Keto-βBoswellic Acid (AKBA) and Other Boswellic Acids in Boswellia sacra Flueck (syn. B. carteri Birdw) and Boswellia serrata Roxb.

Authors:  Giuseppe Mannino; Andrea Occhipinti; Massimo E Maffei
Journal:  Molecules       Date:  2016-10-06       Impact factor: 4.411

3.  Lipooxygenase inhibition in osteoarthritis: a potential symptomatic and disease modifying effect?

Authors:  Maxime Dougados
Journal:  Arthritis Res Ther       Date:  2008-09-19       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.